Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.45 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | MGAM | O43451 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL8669722 | 1.00 | LMNA (0.52) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| Sulfuric Acid SCHEMBL7156177 | 0.89 | LMNA (0.46) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| Sulfuric Acid SCHEMBL7156172 | 0.89 | LMNA (0.46) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL2362 | 0.87 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| Mannitol SCHEMBL3887158 | 0.87 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL17813049 | 0.87 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL8531995 | 0.87 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL23485849 | 0.87 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL24398891 | 0.87 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| Mannitol SCHEMBL20572201 | 0.87 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4102971-A1 | ANTIMICROBIAL COMPOSITIONS CONTAINING PEROXYPHTHALIC ACID AND/OR SALT THEREOF | Virox Technologies Inc. (CA) | 2022-12-21 | — | — | EP | disclosed |
| WO-2021161148-A1 | ANTIMICROBIAL COMPOSITIONS CONTAINING PEROXYPHTHALIC ACID AND/OR SALT THEREOF | VIROX TECHNOLOGIES INC. (CA) | 2021-08-19 | — | — | WO | disclosed |
| CN-103547580-B | Substituted fused tricyclic compounds, compositions and medical uses thereof | 阿迪维纳斯疗法有限公司 | 2016-12-07 | — | — | CN | disclosed |
| CN-105473160-A | Compositions and methods for treating non-healing wounds | KLOX TECH INC | 2016-04-06 | — | — | CN | disclosed |
| CN-105163759-A | Biophotonic materials and uses thereof | KLOX TECHNOLOGIES INC | 2015-12-16 | — | — | CN | disclosed |
| CN-104755101-A | Chromophore combinations for biophotonic uses | KLOX TECHNOLOGIES INC | 2015-07-01 | — | — | CN | disclosed |
| CN-104010635-A | A pain relief composition, comprising a trpv1 selective agonist, and manufacture and uses thereof | API GENESIS LLC | 2014-08-27 | — | — | CN | disclosed |
| CN-102958556-A | Nanopatterned medical device with enhanced cellular interaction | KIMBERLY CLARK CO | 2013-03-06 | — | — | CN | disclosed |
| CN-101444647-B | Polylactic acid membrane of surface-modified with microcapsule carrying hamocura and preparation method thereof | BEIJING INST TECHNOLOGY | 2012-11-14 | — | — | CN | disclosed |
| CN-101444647-A | Polylactic acid membrane of surface-modified with microcapsule carrying hamocura and preparation method thereof | BEIJING INST TECHNOLOGY (CN) | 2009-06-03 | — | — | CN | disclosed |